Primo Chemicals Ltd Valuation Shifts to Fair Amid Mixed Market Performance

Valuation Metrics and Recent Changes

As of 7 May 2026, Primo Chemicals trades at ₹25.07, down 1.61% from the previous close of ₹25.48. The stock’s 52-week range spans from ₹16.21 to ₹31.44, indicating a moderate volatility band. The company’s P/E ratio currently stands at 38.80, a figure that has contributed to the downgrade in valuation grade from very attractive to fair. This P/E is considerably higher than some peers in the commodity chemicals space, such as Gulshan Polyols (P/E 27.57) and TGV Sraac (P/E 9.15), but lower than the very expensive Titan Biotech (P/E 71.62) and Sanstar (P/E 85.9).

Similarly, the price-to-book value ratio of Primo Chemicals is 1.49, which aligns with a fair valuation perspective. This contrasts with the broader peer group where valuations vary widely, with some companies like Stallion India and Sanstar trading at elevated multiples, while others such as Nitta Gelatin maintain more modest valuations (P/E 11.22, P/BV not specified).

Operational Efficiency and Profitability Indicators

Primo Chemicals’ return on capital employed (ROCE) and return on equity (ROE) remain subdued at 2.95% and 3.83% respectively, signalling limited profitability and operational efficiency. These figures are critical in understanding the valuation context, as low returns often justify more conservative price multiples. The company’s EV to EBITDA ratio of 10.70 is moderate but eclipsed by peers like Titan Biotech (58.36) and Stallion India (38.23), indicating that Primo Chemicals is not excessively priced on an enterprise value basis relative to earnings before interest, tax, depreciation and amortisation.

Comparative Peer Analysis

Within the commodity chemicals sector, Primo Chemicals’ valuation grade of ‘fair’ places it in the middle tier. While it is no longer considered very attractive, it remains more reasonably priced than several peers categorised as ‘very expensive’ or ‘expensive’. For instance, Platinum Industrials trades at a P/E of 29.89 with an ‘expensive’ valuation grade, while Jyoti Resins is also marked as expensive with a P/E of 14.89. On the other hand, companies like TGV Sraac and Gulshan Polyols are rated ‘very attractive’ with significantly lower P/E ratios, suggesting that investors may find better value propositions elsewhere in the sector.

Stock Performance Relative to Sensex

Primo Chemicals has delivered mixed returns compared to the benchmark Sensex over various time frames. Notably, the stock outperformed the Sensex over short-term periods, with a 1-week return of 9.86% versus Sensex’s 0.60%, and a 1-month return of 11.42% against 5.20% for the index. Year-to-date, Primo Chemicals posted a positive 4.68% return while the Sensex declined by 8.52%. However, over longer horizons, the stock has underperformed significantly; a 3-year return of -66.14% contrasts sharply with the Sensex’s 27.69% gain. Over five years, Primo Chemicals returned 23.19%, lagging behind the Sensex’s 59.26%, though the 10-year return of 862.01% far exceeds the benchmark’s 209.01%, highlighting a strong historical growth trajectory tempered by recent volatility.

Valuation Grade Upgrade and Market Sentiment

On 5 May 2026, Primo Chemicals’ Mojo Grade was upgraded from Sell to Hold, with a current Mojo Score of 61.0. This reflects a cautious improvement in market sentiment, acknowledging the company’s fair valuation and potential for stabilisation. The micro-cap status of the company, however, implies higher risk and lower liquidity, factors that investors should weigh carefully.

Enterprise Value Multiples and Growth Prospects

The company’s EV to EBIT ratio is notably high at 46.50, suggesting that earnings before interest and tax are valued expensively relative to enterprise value. This contrasts with the EV to EBITDA ratio of 10.70, which is more moderate and indicates some operational earnings cushion. The EV to capital employed and EV to sales ratios stand at 1.37 and 1.30 respectively, signalling that the market values the company’s capital base and sales at reasonable multiples. The PEG ratio of 0.12 is low, which typically indicates undervaluation relative to growth, but given the low ROCE and ROE, this may reflect market caution about sustainable growth prospects.

Investment Considerations and Outlook

Investors evaluating Primo Chemicals should consider the recent shift in valuation from very attractive to fair as a signal of changing market expectations. While the stock’s short-term price momentum has been positive relative to the Sensex, the company’s modest profitability metrics and elevated P/E ratio suggest caution. The micro-cap classification adds an element of risk, particularly in terms of liquidity and volatility.

Comparative analysis indicates that while Primo Chemicals is not the most expensive stock in its sector, there are peers offering more compelling valuations and stronger operational metrics. The low PEG ratio may attract growth-oriented investors, but the subdued returns on capital and equity temper enthusiasm.

Overall, Primo Chemicals appears to be in a phase of valuation recalibration, balancing historical growth achievements against recent operational challenges and market conditions. Investors should monitor upcoming quarterly results and sector developments closely to reassess the stock’s attractiveness in the evolving commodity chemicals landscape.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →